CAR T-cell Therapies Targeting CD20 Show Early Potential to Prevent, Mitigate NHL Relapse

Retrieved on: 2021-06-08 19:15:32

Tags for this article:

Click the tags to see associated articles and topics

CAR T-cell Therapies Targeting CD20 Show Early Potential to Prevent, Mitigate NHL Relapse. View article details on hiswai:

Excerpt

... and BMS, there are also several anti-CD19 monoclonal antibodies on the market or in development, such as tafasitamab (Morphosys' Monjuvi) and ...

Article found on: www.precisiononcologynews.com